|
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||
|
||||||||||||||||
|
||||||||||||||||
 |
|
 |
 |
|
|
|
|
|
|
|
|
 
Please click here to visit the Osteohealth site. |
|
|
The Osteohealth Company: Revolutionizing Regeneration Luitpold Pharmaceuticals' Osteohealth Company division is a distributor of bone grafting products used by dental professionals throughout North America, Central and South America, Australia, and Southeast Asia. With recent advances made in implant dentistry, the fields of bone grafting and guided bone regeneration (GBR) have experienced tremendous growth. Procedures to repair and grow new bone, which was unheard of not long ago, are now a part of routine dental surgical care. Bone grafting is a surgical procedure that replaces missing bone with a material called a bone graft. Not only does this replace the missing bone, it also helps the body regrow lost bone. This regrown bone strengthens the grafted area by forming a "bridge" between the existing bone and the graft, and over time the newly formed bone will actually replace much of the grafted material. The GBR procedure uses a membrane that is placed over the area of the bone graft. This membrane aids in the growth of new bone and also cuts down the risk of scar tissue at the grafted area. Two products have helped Osteohealth become a market leader in the industry: Bio-Oss® and Bio-Gide®; Bio-Oss® is a safe, effective bone graft material that has been used in over one million patients. Because Bio-Oss® is so similar to human bone, it is highly successful in supporting new bone growth and in many cases the need for additional surgery to harvest the patient's own bone becomes unnecessary. Bio-Gide® is a thin resorbable membrane made from natural collagen. It is placed directly over the area of the grafted material and encourages new bone to form. It also prevents the growth of scar tissue at the grafted site. In 1999, Osteohealth created a direct sales and marketing operation in China by establishing an office in Beijing. The Osteohealth Company is currently working on research and development of new products to generate tissue for the treatment of periodontal and bone defects of the jaw, head, and face. In December 2003, Luitpold established a worldwide strategic alliance with BioMimetic Pharmaceuticals, Inc. for the research, development, marketing, and manufacture of new products. More than ever, advances in dentistry are leading to new and expanded methods of treatments for patients. Luitpold is proud of the cutting-edge products produced by its Osteohealth Company to aid in bone grafting and GBR. To learn more about the Osteohealth Company, click here. Bio-Oss®, Bio-Gide®, and Bio-Oss Collagen® are marketed under exclusive license from the manufacturer of the products, Ed. Geistlich Soehne AG fuer Chemische Industrie, Wolhusen, Switzerland |
|
|
|
|||||
|
|
|
|
|
|||